Are acetowhite lesions of the cervix correlated to the presence of Epstein-Barr virus DNA?

被引:6
|
作者
Voog, E [1 ]
Ricksten, A [1 ]
Stenglein, M [1 ]
Jonassen, F [1 ]
Ternesten, A [1 ]
Ryd, W [1 ]
Lowhagen, GB [1 ]
机构
[1] SAHLGRENS UNIV HOSP,DEPT DERMATOL & VENEROL,S-41345 GOTHENBURG,SWEDEN
关键词
EBV; HPV; cervix; PCR;
D O I
10.1258/0956462971920488
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The purpose of this study was to investigate whether Epstein-Barr virus (EBV) is associated with acetowhite lesions of the portio cervix, demonstrating koilocytosis and/or cervical intraepithelial neoplasia (CIN) I-III. The study group comprised 37 women admitted to the Department of Gynaecology and Obstetrics, Sahlgrenska University Hospital, Goteborg because of pathological colposcopy or cytology of the portio cen ix. Colposcopically, all exhibited acetowhite lesions of the portio cervix. Cells were sampled with a cytobrush for examination for EBV and human papillomavirus (HPV) DNA by polymerase chain reaction (PCR) and a biopsy was taken for histopathology. Biopsies from 5 patients positive for EBV by PCR in cervical cell samples were examined by an in situ hybridization technique for EBER (Epstein-Barr virus encoded RNA), RNAs expressed in latent EBV infection. The control group consisted of women attending the Department of Dermato-Venereology at the same hospital for STD check-up. These had a normal cytology and no signs of acetowhiteness of the portio cervix. In the study group, EBV DNA was found in 30% and HPV DNA in 51%. In the control group 57% exhibited EBV DNA and 23% HPV DNA. EBV was not found to be a predictive factor in the development of koilocytosis and/or CIN I-III. HPV was a predictive factor in acetowhite, koilocytotic lesions. No expression of EBER was found in the 5 biopsies examined by in situ hybridization.
引用
收藏
页码:432 / 436
页数:5
相关论文
共 50 条
  • [21] Epstein-Barr Virus and Neurological Diseases
    Zhang, Nan
    Zuo, Yuxin
    Jiang, Liping
    Peng, Yu
    Huang, Xu
    Zuo, Lielian
    FRONTIERS IN MOLECULAR BIOSCIENCES, 2022, 8
  • [22] Epstein-Barr virus and multiple sclerosis
    Skliar, A., I
    Torianyk, I. I.
    Osolodchenko, T. P.
    Ponomarenko, S., V
    PATHOLOGIA, 2020, (03): : 390 - 401
  • [23] Epstein-Barr virus and nasopharyngeal carcinoma
    Lawrence SYoung
    Christopher WDawson
    ChineseJournalofCancer, 2014, 33 (12) : 581 - 590
  • [24] Epstein-Barr virus and nasopharyngeal carcinoma
    Young, Lawrence S.
    Dawson, Christopher W.
    CHINESE JOURNAL OF CANCER, 2014, 33 (12) : 581 - 590
  • [25] Vaccine Development for Epstein-Barr Virus
    Cohen, Jeffrey I.
    HUMAN HERPESVIRUSES, 2018, 1045 : 477 - 493
  • [26] Epstein-Barr virus strain characterization
    Munch, M
    APMIS, 1998, 106 (04) : 425 - 433
  • [27] Molecular diagnosis of Epstein-Barr virus
    Häusler, M
    Scheirauer, S
    Ritter, K
    Kleines, M
    EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2003, 3 (01) : 81 - 92
  • [28] Epstein-Barr virus infection in gliomas
    Limam, S.
    Missaoui, N.
    Mestiri, S.
    Yacoubi, M. T.
    Krifa, H.
    Selmi, B.
    Mokni, M.
    CURRENT RESEARCH IN TRANSLATIONAL MEDICINE, 2019, 67 (04) : 129 - 133
  • [29] Epstein-Barr virus in hepatocellular carcinogenesis
    Wei Li Bao-An Wu Yong-Ming Zeng Guang-Can Chen Xin-Xin Li Jun-Tian Chen Yu-Wen Guo Department of General Surgery
    World Journal of Gastroenterology, 2004, (23) : 3409 - 3413
  • [30] The Association of Epstein-Barr Virus With Cancer
    Patel, Pragnesh D.
    Alghareeb, Rahmah
    Hussain, Afshan
    Maheshwari, Marvi, V
    Khalid, Nabeeha
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (06)